STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

NCT00006357 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

91

Enrollment

NETWORK

Sponsor class

Conditions

Endometrial Cancer
Gastrointestinal Stromal Tumor
Ovarian Cancer
Sarcoma
Small Intestine Cancer

Interventions

DRUG: imatinib mesylate

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC